Skip to main content
Premium Trial:

Request an Annual Quote

Cepheid Names Vysis Chief to Be CEO

NEW YORK, April 15 - Cepheid said today it has hired John L. Bishop to be CEO.

Bishop, who will also become a member of Cepheid's board, succeeds co-founder Thomas L. Gutshall, who will continue as chairman.


"Clinical diagnostics represents a major untapped opportunity for Cepheid's DNA testing products, and John's outstanding record of success in creating and expanding new markets will be a tremendous asset," Gutshall said in a statement.

Before joining Cepheid, Bishop was president and CEO of Vysis, which he helped create. Bishop took the company public in 1998, and oversaw its sale to Abbott Laboratories in December 2001 for roughly $355 million.